Gadoxetic acid
Systematic (IUPAC) name | |
---|---|
2-[[2-[bis(2-oxido-2-oxoethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(2-oxido-2-oxoethyl)amino]ethyl]amino]acetate; gadolinium(+3) cation | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 135326-11-3 |
ATC code | V08CA10 |
PubChem | CID 219084 |
UNII | 3QJA87N40S |
KEGG | D08008 |
ChEMBL | CHEMBL1201769 |
Chemical data | |
Formula | C23H30GdN3O11 |
Molar mass | 681.75 g/mol |
(what is this?) (verify) |
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.[1]
References
- ↑ "Eovist - Homepage". Retrieved 2009-03-22.
|
This article is issued from Wikipedia - version of the Monday, February 03, 2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.